Ttk Healthcare Limited (TTKHLTCARE)

Loading page…

Ttk Healthcare Limited (TTKHLTCARE) · mywealthgrid

About

TTK Healthcare operates in the Diversified industry within the Industrials sector, with a market capitalisation of ₹1,632.36 Cr and quarterly standalone revenue typically in the ₹190–260 Cr range. Recent quarters show volatility in both revenue and profitability. The company has maintained a consistent dividend payout policy and promoter ownership stands at 74.56%.

Face value: ₹10

Market cap

₹1,428 Cr

P/E

19.3×

P/B

1.3×

Dividend yield

ROE

ROCE

8.2%

Debt / equity

0.02

OPM

3.1%

EPS (TTM)

₹52.3

Book value

₹789.0

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Operating margin volatility: OPM ranged from 1.18% (Jun 2025) to 6.3% (Mar 2025), creating earnings uncertainty and making profitability trajectories difficult to predict.
Low capital efficiency: ROE of 6.03% is weak and suggests poor returns on shareholder capital despite the company's market position.
Revenue inconsistency: Quarterly standalone revenue has fluctuated between ₹190 and ₹257 Cr over eight quarters—researchers should verify whether this reflects market demand swings or execution challenges.
Valuation disconnect: The PE of 22.07 is relatively high given an ROE of only 6.03% and margin volatility—verify that near-term earnings growth justifies the multiple.

Generated analysis · source review pending

Growth drivers

Y-o-Y revenue growth: Jun 2026 standalone revenue of ₹257.56 Cr represents 13.8% growth versus ₹226.43 Cr in Jun 2025, suggesting underlying demand momentum.
Operating margin recovery: OPM improved sharply to 5.72% in Jun 2026 from 1.18% in Jun 2025, indicating operational improvements or cost control gains—verify whether this trend is structural or cyclical.
Net profit acceleration: Jun 2026 net profit of ₹21.28 Cr is 63.7% higher than Jun 2025's ₹13 Cr despite revenue growth of only 13.8%—verify what segments or initiatives drove this acceleration.
Capital light model: D/E of 0.02 affords capacity for growth investments; researchers should verify management's capital allocation priorities.

Generated analysis · source review pending

2,528 historical price candles were omitted because the exchange source has not been verified.

₹1,013.0-2%1Y

Quick read

rule-based

Pros

+Almost debt-free (debt/equity 0)
+Comfortable interest coverage of 30.6×
+Dividend payout of 38.1% of profit
+High promoter holding of 74.6% with no pledge

Cons

−Low return on equity of 6.8% (3-yr avg)
−Thin operating margin of 3.1%
−Modest revenue growth of 6.1% a year over the last 5 years

Research score

Structured signal from quality, growth, valuation and momentum.

48/100

Business quality: 43
Growth: 46

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	515	533	559	628	646	637	599	725	753	801	857
COGS	-229	-242	-251	263	260	252	281	348	338	369	403
Gross profit	—	—	—	365	386	385	318	377	415	433	454
	712	735	767	316	357	350	296	346	377	398	428
	32	39	43	50	28	35	22	31	37	35	26
OPM %	6.2%	7.4%	7.7%	7.9%	4.4%	5.5%	3.6%	4.3%	5%	4.3%	3.1%
Depreciation	—	12	—	15	14	14	13	13	13	8	9
Interest	3	3	4	3	3	2	3	5	3	3	3
	6	6	7	8	9	18	42	643	63	85	68
Profit before tax	36	30	36	39	19	37	48	657	84	108	83
Tax	13	11	—	15	7	-9	6	17	21	27	17
Tax %	36.2%	35.7%	—	37.9%	36.6%	-25.3%	13.2%	2.6%	25.3%	24.6%	20.5%
	23	19	24	24	12	46	42	640	63	82	66
PAT margin %	4.4%	3.6%	4.2%	3.9%	1.9%	7.3%	6.9%	88.2%	8.4%	10.2%	7.7%
EPS (₹)	—	—	25.8	17.3	8.7	32.9	29.4	452.7	44.5	57.8	46.5
EPS adjusted (₹)	—	—	16.7	17.3	8.7	32.9	29.4	452.7	44.5	57.8	46.5
	—	—	19.4%	29%	34.4%	18.3%	34%	2.2%	22.5%	17.3%	21.5%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	14	14	14	14	14	14	14	14	14
Reserves	—	237	235	281	316	939	987	1,051	1,101
	—	28	28	18	20	26	21	24	24
	—	136	154	182	209	191	178	192	190
Total equity & liabilities	—	416	431	494	559	1,170	1,201	1,281	1,329
	110	98	89	85	80	71	75	81	73
CWIP	—	2	9	0	0	3	1	0	1
Investments	—	13	9	13	15	13	13	11	9
	—	304	325	395	463	1,083	1,112	1,189	1,246
Total assets	—	416	431	494	559	1,170	1,201	1,281	1,329

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Consumer Products	241.28	18.35	50.49	51.44	—	—
Protective Devices	216.51	-10.54

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	58.2%	59.7%	60.5%	53%	52%	55.1%	54%	52.9%
EBITDA margin %	7.9%	4.4%	5.5%	3.6%	4.3%	5%	4.3%	3.1%
EBIT margin %	5.6%	2.2%	3.3%	1.5%	2.6%	3.2%	3.3%	2%
PAT margin %	3.9%	1.9%	7.3%	6.9%	88.2%	8.4%	10.2%	7.7%
Working capital
Receivable days	47	43	34	33	46	42	41	47
Inventory days	77	101	102	102	89	105	107	98
Payable days	101	121	142	134	131	110	106	83
NWC days	22	23	-5	1	4	36	43	63
Leverage
Current ratio	1.73	1.74	1.99	2.06	5.06	5.5	5.23	5.91
Debt to EBITDA	0.57	0.99	0.5	0.93	0.81	0.58	0.7	0.91
Debt to equity	0.11	0.11	0.06	0.06	0.03	0.02	0.02	0.02
Interest coverage	12.6	6.9	14	7.9	12.8	31.5	29.4	30.6
Asset turnover	1.51	1.5	1.29	1.07	0.62	0.63	0.63	0.65
Return ratios
Return on assets %	5.9%	2.9%	9.4%	7.4%	54.7%	5.2%	6.4%	4.9%
Return on capital employed %	16.5%	8.8%	11%	7.9%	10.3%	8.8%	9.4%	8.2%
Return on equity %	9.7%	4.9%	15.8%	12.6%	67.1%	6.3%	7.7%	5.9%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%	74.56%
	1.85%	0%	1.85%	1.87%	1.9%	1.9%	1.9%	1.89%	1.9%	1.89%	1.9%	1.86%
	3.22%	4.99%	1.14%	1.14%	1.14%	1.14%	1.14%	1.18%	1.18%	1.08%	1.11%	2.19%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	20.37%	20.45%	22.45%	22.43%	22.4%	22.4%	22.4%	22.37%	22.36%	22.47%	22.43%	21.39%
No. of shareholders	—	—	—	—	—	—	—	—	16,134	22,481	23,686	22,809

Promoter holding up 0 percentage points since Sep 2023.

10 deals · 24 Mar 2023 – 17 Mar 2025

Date	Client	Type	Venue	Side	Quantity	Price	Value
17 Mar 2025	UNO METALS LTD	Bulk	NSE	Sell	76,500	₹1,124.24	₹8.60 Cr
31 Jul 2024	UNO METALS LTD	Bulk	NSE	Buy	97,513	₹1,541.59	₹15.03 Cr
31 Jul 2024	CLUBMILLIONAIRE FINANCIAL SERVICES PRIVATE LIMITED	Bulk	NSE	Sell	87,335	₹1,541.13	₹13.46 Cr
24 Mar 2023	MCAP INDIA FUND LIMITED	Bulk	BSE	Sell	2,45,873	₹910.00	₹22.37 Cr
24 Mar 2023	ABAKKUS ASSET MANAGER LLP	Bulk	BSE	Buy	1,31,788	₹911.08	₹12.01 Cr
24 Mar 2023	ABAKKUS ASSET MANAGER LLP	Block	BSE	Buy	1,30,488	₹910.00	₹11.87 Cr
24 Mar 2023	MCAP INDIA FUND LIMITED	Block	BSE	Sell	1,30,488	₹910.00	₹11.87 Cr
24 Mar 2023	ABAKKUS DIVERSIFIED ALPHA FUND	Block	BSE	Buy	1,15,385	₹910.00	₹10.50 Cr
24 Mar 2023	MCAP INDIA FUND LIMITED	Block	BSE	Sell	1,15,385	₹910.00	₹10.50 Cr
24 Mar 2023	ABAKKUS DIVERSIFIED ALPHA FUND	Bulk	BSE	Buy	1,15,385	₹910.00	₹10.50 Cr

1–10 of 10

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. RAGHUNATHAN THIRUVALLUR THATTAIExecutive Director-Chairperson related to Promoter
Mr. RAJIV TULSHANNon-Executive - Non Independent Director
B V K Durga PrasadChief Financial Officer
Mr. KRISHNAMURTHY SHANKARANNon-Executive - Non Independent Director
Mr. VIJAYARAGHAVACHARI RANGANATHANNon-Executive - Independent Director
Mr. SUBRAMANIAM KALYANARAMANExecutive Director-CEO-MD
Mr. MUKUND THIRUVALLUR THATTAINon-Executive - Non Independent Director
Mr. MURALI NEELAKANTANNon-Executive - Independent Director
Mrs. HASTHA SHIVARAMAKRISHNANNon-Executive - Independent Director
Mrs. SUBASHREE ANANTKRISHNANNon-Executive - Independent Director
Mr. VAITHIANATHAN SUNDARESAN

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Ttk Healthcare Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

20

Final dividend17 Jul 2026 · ex-date₹10
Final dividend18 Jul 2025 · ex-date₹10
Final dividend16 Jul 2024 · ex-date₹10
Final dividend18 Jul 2023 · ex-date₹10
Final dividend26 Jul 2022 · ex-date₹10
Final dividend12 Aug 2021 · ex-date₹6
Final dividend3 Sept 2020 · ex-date₹3
Final dividend1 Aug 2019 · ex-date₹5
Dividend dividend2 Aug 2018 · ex-date₹5
Dividend dividend27 Jul 2017 · ex-date₹5
Dividend dividend28 Jul 2016 · ex-date₹5
Dividend dividend30 Jul 2015 · ex-date₹4.5
Dividend dividend13 Aug 2014 · ex-date₹4
Dividend dividend16 Jul 2013 · ex-date₹4
Dividend dividend3 Aug 2012 · ex-date₹4
Dividend dividend15 Jul 2011 · ex-date₹4
Dividend dividend16 Jul 2010 · ex-date₹3.5
Dividend dividend14 Aug 2009 · ex-date₹3
Dividend dividend14 Aug 2008 · ex-date₹3
Dividend dividend14 Aug 2007 · ex-date₹2.5

1

Board meeting to consider results6 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

12 announcementsExport CSV

22 Sept 2026, 11:05 amInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	58.2%	59.7%	60.5%	53%	52%	55.1%	54%	52.9%
EBITDA margin %	7.9%	4.4%	5.5%	3.6%	4.3%	5%	4.3%	3.1%
EBIT margin %	5.6%	2.2%	3.3%	1.5%	2.6%	3.2%	3.3%	2%
PAT margin %	3.9%	1.9%	7.3%	6.9%	88.2%	8.4%	10.2%	7.7%
Working capital
Receivable days	47	43	34	33	46	42	41	47
Inventory days	77	101	102	102	89	105	107	98
Payable days	101	121	142	134	131	110	106	83
NWC days	22	23	-5	1	4	36	43	63
Leverage
Current ratio	1.73	1.74	1.99	2.06	5.06	5.5	5.23	5.91
Debt to EBITDA	0.57	0.99	0.5	0.93	0.81	0.58	0.7	0.91
Debt to equity	0.11	0.11	0.06	0.06	0.03	0.02	0.02	0.02
Interest coverage	12.6	6.9	14	7.9	12.8	31.5	29.4	30.6
Asset turnover	1.51	1.5	1.29	1.07	0.62	0.63	0.63	0.65
Return ratios
Return on assets %	5.9%	2.9%	9.4%	7.4%	54.7%	5.2%	6.4%	4.9%
Return on capital employed %	16.5%	8.8%	11%	7.9%	10.3%	8.8%	9.4%	8.2%
Return on equity %	9.7%	4.9%	15.8%	12.6%	67.1%	6.3%	7.7%	5.9%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
3m India Limited3MINDIA3MINDIA	₹34,798 Cr	₹34,798 Cr	₹4,186 Cr	₹791 Cr	18.1%	₹611 Cr	13.9%	40%	30.5%	19
Godrej Industries LimitedGODREJINDGODREJIND	₹34,340 Cr	₹85,378 Cr	₹23,225 Cr	₹2,419 Cr	10.1%	₹1,176 Cr	10.9%	12.6%	11.6%	1,365
Dcm Shriram LimitedDCMSHRIRAMDCMSHRIRAM	₹14,138 Cr	₹16,950 Cr	₹14,593 Cr	₹1,530 Cr	10.5%	₹1,436 Cr	6%	12%	11.6%	126
Balmer Lawrie & Company LimitedBALMLAWRIEBALMLAWRIE	₹2,724 Cr	₹2,799 Cr	₹2,785 Cr	₹367 Cr	12.9%	₹279 Cr	10%	13.1%	13.7%	35
Ttk Healthcare LimitedTTKHLTCARETTKHLTCARE	₹1,428 Cr	₹1,452 Cr	₹888 Cr	₹38 Cr	3.1%	₹74 Cr	7.7%	8.2%	6%	63
Empire Industries LtdEMPINDEMPIND	₹636 Cr	₹778 Cr	₹498 Cr	₹31 Cr	10.3%	₹23 Cr	5.1%	13.4%	11.2%	143
Panth Infinity LtdPANTHPANTH	₹58 Cr	₹133 Cr	₹30 Cr	₹2 Cr	6.3%	₹1 Cr	4.7%	10%	18.9%	183
Krypton Industries LtdKRYPTONQKRYPTONQ	₹48 Cr	₹69 Cr	₹52 Cr	₹7 Cr	13.1%	₹1 Cr	5.1%	14.4%	8.4%	224
Galactico Corporate Services LtdGALACTICOGALACTICO	₹35 Cr	₹42 Cr	₹24 Cr	₹2 Cr	7.8%	₹2 Cr	6.7%	6.3%	4.8%	-40
Swasti Vinayaka Art And Heritage Corporation LtdSVARTCORPSVARTCORP	₹29 Cr	₹37 Cr	₹8 Cr	₹3 Cr	24.9%	₹2 Cr	18.3%	19.4%	20%	618
Billwin Industries LtdBILLWINBILLWIN	₹19 Cr	—	₹8 Cr	₹1 Cr	10.8%	₹0 Cr	5.8%	—	—	—
HCKK Ventures LtdHCKKVENTUREHCKKVENTURE	₹12 Cr	₹12 Cr	₹0 Cr	₹-0 Cr	-853.3%	₹-1 Cr	-653.3%	-27.3%	-25.1%	0

Date	Category	Subject	Filing
22 Sept 2026, 11:05 am	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
4 Sept 2026, 2:50 pm	Company Update General	Announcement Under Regulation 30 Of SEBI LODR Regulations.	PDF
2 Sept 2026, 2:37 pm	Company Update General	Appointment Of Tax Auditor Of The Company	PDF
27 Aug 2026, 3:46 pm	Company Update General	Intimation From M/S Aiyar & Co. Regarding Their Inability To Continue As Tax Auditors	PDF
27 Aug 2026, 2:12 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
27 Jul 2026, 5:48 pm	Board Meeting	Board Meeting Intimation for Board Meeting Intimation	PDF
24 Jul 2026, 6:22 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
24 Jul 2026, 2:46 pm	AGM/EGM AGM	Chairman'S Speech - 68Th Annual General Meeting Of The Company - July 24, 2026	PDF

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	18	25	17	20	96	45	-26	-5	-4	-21
	5	-23	10	-13	-77	-31	33	28	20	52
	-23	-7	-31	-10	-17	-9	-12	-22	-18	-18
Net cash flow	0	-4	-4	-4	2	5	-6	2	-2	13
Free cash flow	12	21	13	8	95	39	-38	-15	-17	-27
CFO / Operating profit %	45.3%	58.6%	34.9%	70.1%	276.4%	206%	-83.2%	-13.2%	-11.4%	-80.8%

Ttk Healthcare Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Segment results

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

20

1

Announcements

20

1

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Segment results

Compounded sales growth

Compounded profit growth

Return on equity

Animal Welfare · revenue

Ttk Healthcare Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Dividends20

Board meetings1

Announcements

Dividends20

Board meetings1

Ratio timeline

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Quarterly record

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Segment results

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Animal Welfare · revenue

20

1

20

1